Acquisitions - (Tables)

12 Months Ended

Dec. 31, 2019

Schedule of Business Acquisitions, by Acquisition

The following table summarizes the consideration transferred and the allocation of the estimated accumulated cost, including tax adjustments, to the assets acquired and liabilities assumed (in millions):



	Amounts
Cash purchase price	$	13,400
Transaction costs	40
Accumulated cost (consideration transferred)	$	13,440

Intangible assets:
Developed-product-technology rights	$	13,007
Marketing-related rights	195
Inventory	367
Deferred tax liability, net	(24		)
Deferred credit	(96		)
Other liabilities, net	(9		)
Total assets acquired, net	$	13,440

Aggregate acquisition date consideration to acquire an entity

The aggregate share acquisition date consideration to acquire the remaining 50% ownership in K-A and the fair value of Amgen’s preacquisition investment consisted of the following (in millions):



	Amounts
Total cash paid to Kirin	$	780
Fair value of contingent consideration obligation	45
Loss on settlement of preexisting relationship	(168		)
Total consideration transferred to acquire K-A	657

Fair value of Amgen’s investment in K-A	825
Total acquisition date fair value	$	1,482